KTRA
Kintara Therapeutics (KTRA)
$19
About Kintara Therapeutics (KTRA)
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Details
Daily high
$0.20
Daily low
$0.18
Price at open
$0.20
52 Week High
$4.59
52 Week Low
$0.08
Market cap
10.5M
Dividend yield
0.00%
Volume
1.4M
Avg. volume
5.0M
P/E ratio
-.09
Kintara Therapeutics News
Details
Daily high
$0.20
Daily low
$0.18
Price at open
$0.20
52 Week High
$4.59
52 Week Low
$0.08
Market cap
10.5M
Dividend yield
0.00%
Volume
1.4M
Avg. volume
5.0M
P/E ratio
-.09